Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 521-526

  Buerger, Horst ^b   Otterbach, Friedrich ^b   Simon, Ronald ^b   Schäfer, Karl Ludwig ^b   Poremba, Christopher ^b   Diallo, Raihanatou ^b   Brinkschmidt, Christian ^b   Dockhorn Dworniczak, Barbara ^b   Boecker, Werner ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE

Author keywords

Breast cancer; CGH; Cytogenetics

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032694072     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B     Document Type: Article

References (27)

1. Simon R, Bürger H, Brinkschmidt C, Böcker W, Hertle L, Terpe H-J. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998; 185: 345-351.
2. Bürger H, Otterbach F, Simon R, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast - evidence of multiple genetic pathways. J Pathol 1998; 187: 396-402.
3. Ellis IO, Elston CW. Tumors of the breast. In Diagnostic Histopathology of Tumours, Fletcher CDM (ed.). Churchill Livingstone: Edinburgh, 1995; 635-689.
4. Bier B, Bankfalvi A, Grote L, et al. Wet autoclave pretreatment for immunohistochemical demonstration of oestrogen receptors in routinely-processed breast carcinoma tissue. Histochem J 1995; 27: 148-154.
5. Brinkschmidt C, Christiansen H, Terpe HJ, et al. Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in paediatric tumour pathology. J Pathol 1997; 181: 394-400.
6. Sauter G, Deng G, Moch H, et al. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am J Pathol 1994; 144: 756-766.
7. Fantl V, Smith R, Brookes S, Dickson C, Peters G. Chromosome 11q13 abnormalities in human breast cancer [see comments]. Cancer Surv 1993; 18: 77-94.
8. Courjal F, Theillet C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res 1997; 57: 4368-4377.
9. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998; 21: 177-184.
10. Ried T, Just KE, Holtgreve Grez H, et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 1995; 55: 5415-5423.
11. Isola JJ, Kallioniemi OP, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995; 147: 905-911.
12. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167-180.
13. Hermsen MAJA, Baak JP, Meijer GA, et al. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. J Pathol 1998; 186: 356-362.
14. Sato T, Tanigami A, Yamakawa K, et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990; 50: 7184-7189.
15. Tsuda H, Sakamaki C, Shimamura IC, Hirohashi S. Detection or allele loss on chromosome 16q in DNA isolated from fine needle aspiration specimens of breast tumors. A simulation study using surgically resected specimens. Acta Cytol 1996; 40: 625-630.
16. Tsuda H, Takarabe T, Susumu N, Inazawa J, Okada S, Hirohashi S. Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization. Am J Pathol 1997; 151: 1027-1034.
17. Cleton Jansen AM, Moerland EW, Kuipers M, et al. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 1994; 9: 101-107.
18. Dutrillaux B, Gerbault A, Seureau M, Zafrani B. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 1990; 49: 203-217.
19. Hansen LL, Yilmaz M, Overgaard J, Andersen J, Kruse TA. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res 1998; 58: 2166-2169.
20. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases [see comments]. Lancet 1997; 349: 1505-1510.
21. Lindblom A, Rotstein S, Skoog L, Nordenskjold M, Larsson C. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Res 1993; 53: 3707-3711.
22. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res 1994; 54: 513-517.
23. Nishizaki T, Chew K, Chu L, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997; 74: 513-517.
24. Ro JY, Sneige N, Sahin AA, Silva EG, del-Junco GW, Ayala AG. Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases. Arch Pathol Lab Med 1991; 115: 137-140.
25. Fantl V, Richards MA, Smith R, et al. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 1990; 26: 423-429.
26. Schuuring E, Verhoeven E van, Tinteren H, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992; 52: 5229-5234.
27. Coene ED, Schelfhout V, Winkler RA, et al. Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer. Virchows Arch 1997; 430: 365-372.